Capital Analysts LLC’s ANI Pharmaceuticals ANIP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$363 Buy
+5
New +$385 ﹤0.01% 1629

Other funds holding ANIP

Capital Analysts LLC's ANIP Position: Q3 2026 in Review

Capital Analysts LLC opened a new position in ANI Pharmaceuticals (ANIP) in Q3 2026: 5 shares worth $363. The stake represents ﹤0.01% of the portfolio and ranks #1629 among its holdings.

290 funds tracked by Wall St. Rank hold ANIP as of Q3 2026.

  • Capital Analysts LLC held 5 shares of ANI Pharmaceuticals worth $363 as of Q3 2026.
  • ANI Pharmaceuticals was a new Capital Analysts LLC position in Q3 2026.
  • ANI Pharmaceuticals made up ﹤0.01% of Capital Analysts LLC's portfolio in Q3 2026, its #1629 holding.
  • 290 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q3 2026.

Based on Capital Analysts LLC's 13F filing for Q3 2026, filed 13 Nov 2026.